3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
87
Other hematologic neoplasm
59
Plasma cell
40
CNS
25
Head & Neck
19
Genitourinary
17
Sarcoma
15
Gynecologic
14
Gastrointestinal
14
Dermatologic
13
Thoracic
12
Myeloid
12
Breast
12
Endocrine
4
Other solid neoplasm
3
Classical hematology
3
NET
1
Conditions
Neuroendocrine Tumors
69
Gastro-enteropancreatic neuroendocrine tumor
8
Pheochromocytoma
7
Carcinoma, Neuroendocrine
7
Carcinoid Tumor
7
Adenoma, Islet Cell
7
Paraganglioma
6
Neoplasms
5
Melanoma
5
Breast Neoplasms
5
Thyroid Neoplasms
4
Sarcoma
4
Pancreatic Neoplasms
4
Neuroblastoma
4
Neoplasm Metastasis
4
Carcinoma
4
Serotonin Syndrome
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Neuroectodermal Tumors, Primitive
3
Mesothelioma
3
Meningioma
3
Liver Neoplasms
3
Colonic Neoplasms
3
Cholangiocarcinoma
3
Central Nervous System Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Merkel Cell
3
Carcinoma, Hepatocellular
3
Anus Neoplasms
3
Interventions
olaparib
1
lutetium Lu 177 dotatate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
NET
×
90 days
×
Clear all
NCT06607692
2026-04-14
LUPARPED
Fundación de investigación HM
Phase 1/2
Recruiting
25 enrolled